• All
  • Transaction Details
Healthcare | Corporate Finance Advisory

BioLok Acquired by Healthpoint Capital

  • BioLok International Inc. (OTC) manufactures and distributes products that merge cell biology and technology to develop and market products for the dental implant and tissue regeneration markets
  • Healthpoint Capital (HPC) is a private equity firm exclusively focused on the orthopedic and dental device businesses
  • The Board of Directors of BioLok retained TM Capital to evaluate HPC’s proposed tender offer of $2.15 per share in cash, or $35 million, to acquire 100% of the outstanding shares of the company
  • TM Capital analyzed the transaction and rendered a fairness opinion to BioLok’s Board of Directors which was included in the company’s shareholder documents and public filings

See press Release

has been acquired by

BioLok Acquired by Healthpoint Capital

TM Capital rendered a fairness opinion to the Board of Directors of BioLok International Inc. (OTC) with respect to the sale of BioLok to Healthpoint Capital

Details

For more information, contact our healthcare team at:

healthcare@tmcapital.com

Client Testimonial

”